TYRX Receives FDA Clearance for Use of Antibacterial Envelope With Spinal Cord Neuromodulators

TYRX announced that it has received FDA clearance for marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.

Advertisement

This comes soon after FDA clearance of the envelope for use with vagus nerve stimulators.

 

The AIGISRx N Antibacterial Envelope is intended to hold a spinal cord neuromodulator or vagus nerve stimulator securely in place to provide a stable environment when implanted in the body.

More Articles on Supply Chain:

5 Ways Materials Management Information Systems Can Improve Surgery Center Supply Chain
Mazor Robotics’ Sells Renaissance Spine System to Lawnwood Regional Medical Center
Alphatec Spine Posts $14.5M Q3 Loss After PurGen Device Discontinuation

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.